VAERS reports by lot

Moderna COVID-19 lot 025AZ1A: VAERS reports

25 VAERS reports list lot 025AZ1A as a Moderna COVID-19 vaccine, received between 2021-03-02 and 2023-01-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
12%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2621%
Neurological2419%
Injection-site / Local reaction2016%
Dermatological (non-injection-site)1613%
Musculoskeletal119%
Cardiac / Cardiovascular108%
Gastrointestinal76%
Respiratory54%
Allergic / Anaphylactic32%
Autoimmune / Immune-mediated22%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
North Carolina3
New York2
Montana2
Wisconsin1
West Virginia1
Connecticut1
Illinois1
Utah1
Indiana1
Washington1
Michigan1

Reports by month received

2021-038
2021-043
2021-051
2021-061
2021-084
2021-093
2021-102
2022-031
2022-121
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.